• Company
  • » Management
  • » Board of Directors
  • » Scientific Advisory Board
  • » Investors
  • » Careers
• Science
  • » Neurotrophic Factors
  • » Gene Delivery Technology
  • » Alzheimer's Disease
  • » Parkinson's Disease
  • » ALS
  • » Ocular Diseases
• Pipeline
  • » Clinical Trials
• Investors
  • » Company Fact Sheet
  • » Business Development
• Newsroom
  • » Press Releases
  • » Articles
• Contact

Home | Site Map | Contact | Directions

Newsroom

2002 Press Releases

12.04.02	Ceregene exclusively licenses neurturin gene from Washington University
11.14.02	Ceregene elects new vice president.
10.15.02	Ceregene Awarded SBIR Grant From NIH for Alzheimer's Research
04.18.02	Ceregene expands into new facility.
03.07.02	Ceregene announces additions to management team...
01.28.02	Ceregene-licensed Alzheimer's gene therapy featured on CNN...

Archived Press Releases:

2006 | 2005 | 2004 | 2003 | 2002 | 2001